IMPROVE-IT: Are We Back to 'The Lower the Better' for LDL-C?

Seth Bilazarian and Chris Cannon discuss the role of ezetimibe in secondary prevention and whether super-low LDL-C levels are the way to go.
Source: Medscape Cardiology Podcast - Category: Cardiology Authors: Source Type: podcasts